Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trialParesh Dandona, Bertrand Cariou, Chantal Mathieu et al.|The Lancet Diabetes & Endocrinology|2017Cited by 295
A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum AdjuvantJoanne M. Langley, Ilse Dieussaert, Naresh Aggarwal et al.|The Journal of Infectious Diseases|2016Cited by 67
Add-On Treatment With Zilebesiran for Inadequately Controlled HypertensionAkshay S. Desai, Doja Akande, Wansu Park et al.|JAMA|2025Cited by 33